Roche Notches Big IO Win With Tecentriq/Avastin Combo In First-Line HCC

 
• By Joseph Haas
  
SC1910_Liver-tissue-samples_1052884202_1200.jpg
Roche hopes to offer the first OS improvement in more than a decade in HCC
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D